Public Health Agency of Canada
Symbol of the Government of Canada

E-mail this page





Canada Communicable Disease Report (CCDR) Monthly

2008 Volume 34

Volume 34-11, November 2008

  • A new twist on an old problem: A case of pediatric meningitis caused by multidrug-resistant Streptococcus pneumoniae serotype 19A

Volume 34-10, October 2008

  • Economic analysis of a public program for routine seven valent pneumococcal conjugate vaccine (PCV-7) in infancy, Alberta

Volume 34-09, September 2008

  • Determinants for immunization coverage by age 2 in a population cohort in the Capital Health region, Edmonton, Alberta

Volume 34-08, August 2008

  • Epidemiology of community associated methicillin-resistant Staphylococcus aureus

Volume 34-07, July 2008

  • Influenza In Canada: 2007-2008 Season Update

Volume 34-06, June 2008

  • Cryptococcus gattii Infections on Vancouver Island, British Columbia, Canada: Emergence of a Tropical Fungus in a Temperate Environment
  • Information Update on Currently Approved Vaccines

Volume 34-05, May 2008

  • Investigation of community-associated methicillin-resistant Staphylococcus aureus in a remote northern community, Nunavut, Canada
  • Burden of acute gastrointestinal illness in Canada, 1999-2007: Interim summary of NSAGI activities.
  • Errata/clarifications - Canadian Immunization Guide, 2006, 7th Edition

Volume 34-04, April 2008

  • Outbreak of norovirus gastroenteritis at a university student residence – Edmonton, Alberta, 2006
  • Outbreak of invasive group A streptococcal disease in two hospitals, Ontario, 2003

Volume 34-03, March 2008

  • Influenza in Canada: 2006-2007 Season

Volume 34-02, February 2008

  • Investigation of the second wave (Phase 2) of severe acute respiratory syndrome (SARS) in Toronto, Canada. What happened?

Volume 34-01, January 2008

  • The rising challenge of Lyme borreliosis in Canada
  • Absence of prolyliminopeptidase-negative Neisseria gonorrhoeae strains in Ontario, Canada
  • ERRATUM - Final Report and Recommendations from the National Notifiable Diseases Working Group

 


Advisory Committee Statements and Supplements to the CCDR

An Advisory Committee Statement (ACS)
Canadian Tuberculosis Committee (CTC)
Updated Recommendations on Interferon Gamma Release Assays for Latent Tuberculosis Infection
ACS- 6 - October 2008

An Advisory Committee Statement (ACS)
National Advisory Committee on Immunization (NACI)
Statement on the recommended use of pneumococcal 23-valent polysaccharide vaccine in homeless persons and injection drug users
ACS- 5 - September 2008

An Advisory Committee Statement (ACS)
Committee to Advise on Tropical Medicine and Travel (CATMAT)
Statement on Protection Against Japanese Encephalitis
ACS- 4 - September 2008


An Advisory Committee Statement (ACS)
National Advisory Committee on Immunization (NACI)
Statement on Influenza Vaccination for the 2008-2009 Season
ACS- 3 - July 2008


An Advisory Committee Statement (ACS)
Committee to Advise on Tropical Medicine and Travel (CATMAT)
Statement on Hepatitis Vaccines for Travellers
ACS- 2 - July 2008


An Advisory Committee Statement (ACS)
National Advisory Committee on Immunization (NACI)
Statement on the recommended use of pentavalent human-bovine reassortant rotavirus vaccine
ACS- 1 - January 2008


Supplement
Final Report of Outcomes from the National Consensus Conference for Vaccine-Preventable Diseases in Canada

CCDR Volume 34S2, March 2008

Supplement
Guideline for Investigation of Suspected Transfusion Transmitted Bacterial Contamination

CCDR Volume 34S1, January 2008